Works matching IS 08876924 AND DT 2010 AND VI 24 AND IP 4

Results: 40

ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial differences in leukemia incidence.

Published in:

2010

By:

Yang, W.;
Treviño, L. R.;
Yang, J. J.;
Scheet, P.;
Pui, C.-H.;
Evans, W. E.;
Relling, M. V.;
Treviño, L R

Publication type:

Letter

Proliferation centers in chronic lymphocytic leukemia: the niche where NF-κB activation takes place.

Published in:

2010

By:

Herreros, B.;
Rodríguez-Pinilla, S. M.;
Pajares, R.;
Martínez-Gónzalez, M. Á;
Ramos, R.;
Munoz, I.;
Montes-Moreno, S.;
Lozano, M.;
Sánchez-Verde, L.;
Roncador, G.;
Sánchez-Beato, M.;
de Otazu, R. D.;
Pérez-Guillermo, M.;
Mestre, M. J.;
Bellas, C.;
Piris, M. Á

Publication type:

Letter

A novel exon in AML1-ETO negatively influences the clonogenic potential of the t(8;21) in acute myeloid leukemia.

Published in:

2010

By:

Mannari, D.;
Gascoyne, D.;
Dunne, J.;
Chaplin, T.;
Young, B.

Publication type:

Letter

Trisomy 11 in myelodysplastic syndromes defines a unique group of disease with aggressive clinicopathologic features.

Published in:

2010

By:

Wang, S. A.;
Jabbar, K.;
Lu, G.;
Chen, S. S.;
Galili, N.;
Vega, F.;
Jones, D.;
Raza, A.;
Kantarjian, H.;
Garcia-Manero, G.;
McDonnell, T. J.;
Medeiros, L. J.

Publication type:

journal article

The NDE1 gene is disrupted by the inv(16) in 90% of cases with CBFB–MYH11-positive acute myeloid leukemia.

Published in:

2010

By:

Van der Reijden, B. A.;
Massop, M.;
Simons, A.;
de Witte, T.;
Breuning, M.;
Jansen, J. H.

Publication type:

Letter

NHR4 domain mutations of ETO are probably very infrequent in AML1-ETO positive myeloid leukemia cells.

Published in:

2010

By:

Hackanson, B.;
Abdelkarim, M.;
Jansen, J. H.;
Lübbert, M.;
Lübbert, M

Publication type:

Letter

Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia.

Published in:

Leukemia (08876924), 2010, v. 24, n. 4, p. 699, doi. 10.1038/leu.2009.292

By:

Lancet, J. E.;
Gojo, I.;
Burton, M.;
Quinn, M.;
Tighe, S. M.;
Kersey, K.;
Zhong, Z.;
Albitar, M. X.;
Bhalla, K.;
Hannah, A. L.;
Baer, M. R.

Publication type:

Article

Identification of activated Tnk1 kinase in Hodgkin's lymphoma.

Published in:

2010

By:

Gu, T.-L.;
Cherry, J.;
Tucker, M;
Wu, J.;
Reeves, C.;
Polakiewicz, R. D.

Publication type:

Letter

Biclonal origin prevails in concomitant chronic lymphocytic leukemia and multiple myeloma.

Published in:

2010

By:

Pantic, M.;
Schroettner, P.;
Pfeifer, D.;
Rawluk, J.;
Denz, U.;
Schmitt-Gräff, A.;
Veelken, H.;
Wäsch, R.;
Engelhardt, M.

Publication type:

Letter

Serum metabolome analysis by <sup>1</sup>H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups.

Published in:

Leukemia (08876924), 2010, v. 24, n. 4, p. 788, doi. 10.1038/leu.2009.295

By:

MacIntyre, D. A.;
Jiménez, B.;
Lewintre, E. Jantus;
Martín, C. Reinoso;
Schäfer, H.;
Ballesteros, C. García;
Mayans, J. Ramón;
Spraul, M.;
García-Conde, J.;
Pineda-Lucena, A.

Publication type:

Article

Lenalidomide induces cell death in an MDS-derived cell line with deletion of chromosome 5q by inhibition of cytokinesis.

Published in:

Leukemia (08876924), 2010, v. 24, n. 4, p. 748, doi. 10.1038/leu.2009.296

By:

Matsuoka, A.;
Tochigi, A.;
Kishimoto, M.;
Nakahara, T.;
Kondo, T.;
Tsujioka, T.;
Tasaka, T.;
Tohyama, Y.;
Tohyama, K.

Publication type:

Article

The use of low-dose alemtuzumab in pretreated B-cell chronic lymphocytic leukemia.

Published in:

2010

By:

Tarnani, M.;
D'Arena, G.;
Efremov, D. G.;
Marietti, S.;
S., Sica;
Leone, G.;
Laurenti, L.

Publication type:

Letter

Chronic Myeloid Leukemia CD34+ cells have reduced uptake of imatinib due to low OCT-1 Activity.

Published in:

Leukemia (08876924), 2010, v. 24, n. 4, p. 765, doi. 10.1038/leu.2010.16

By:

Engler, J. R.;
Frede, A.;
Saunders, V. A.;
Zannettino, A. C. W.;
Hughes, T. P.;
White, D. L.

Publication type:

Article

Blocking cytokine signaling along with intense Bcr-Abl kinase inhibition induces apoptosis in primary CML progenitors.

Published in:

Leukemia (08876924), 2010, v. 24, n. 4, p. 771, doi. 10.1038/leu.2009.299

By:

Hiwase, D. K.;
White, D. L.;
Powell, J. A.;
Saunders, V. A.;
Zrim, S. A.;
Frede, A. K.;
Guthridge, M. A.;
Lopez, A. F.;
D'Andrea, R. J.;
To, L. B.;
Melo, J. V.;
Kumar, S.;
Hughes, T. P.

Publication type:

Article

Bimodal distribution of genomic MLL breakpoints in infant acute lymphoblastic leukemia treatment.

Published in:

2010

By:

Jung, R.;
Jacobs, U.;
Krumbholz, M.;
Langer, T.;
Keller, T.;
De Lorenzo, P.;
Valsecchi, M. G.;
van der Velden, V. H. J.;
Moericke, A.;
Stanulla, M.;
Teigler-Schlegel, A.;
Panzer-Gruemayer, E. R.;
van Dongen, J. J. M.;
Schrappe, M.;
den Boer, M. L.;
Pieters, R.;
Rascher, W.;
Metzler, M.

Publication type:

Letter

Aurora kinase inhibitors: novel small molecules with promising activity in acute myeloid and Philadelphia-positive leukemias.

Published in:

Leukemia (08876924), 2010, v. 24, n. 4, p. 671, doi. 10.1038/leu.2010.15

By:

Moore, A. S.;
Blagg, J.;
Linardopoulos, S.;
Pearson, A. D. J.

Publication type:

Article

Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia.

Published in:

2010

By:

Allan, J. M.;
Sunter, N. J.;
Bailey, J. R.;
Pettitt, A. R.;
Harris, R. J.;
Pepper, C.;
Fegan, C.;
Hall, A. G.;
Deignan, L.;
Bacon, C. M.;
Pointon, J. C.;
Houlston, R. S.;
Broderick, P.;
Mainou-Fowler, T.;
Jackson, G. H.;
Summerfield, G.;
Evans, P. A.;
Strefford, J. C.;
Parker, A.;
Oscier, D.

Publication type:

Letter

Development of resistance to dasatinib in Bcr/Abl-positive acute lymphoblastic leukemia.

Published in:

2010

By:

Fei, F.;
Stoddart, S.;
Müschen, M.;
Kim, Y.-M.;
Groffen, J.;
Heisterkamp, N.;
Müschen, M

Publication type:

journal article

MPL mutation effect on JAK2 46/1 haplotype frequency in JAK2V617F-negative myeloproliferative neoplasms.

Published in:

2010

By:

Patnaik, M. M.;
Lasho, T. L.;
Finke, C. M.;
Gangat, N.;
Caramazza, D.;
Siragusa, S.;
Hanson, C. A.;
Pardanani, A.;
Tefferi, A.

Publication type:

Letter

ON012380, a putative BCR-ABL kinase inhibitor with a unique mechanism of action in imatinib-resistant cells.

Published in:

2010

By:

Wu, J.;
Meng, F.;
Ying, Y.;
Peng, Z.;
Daniels, L.;
Bornmann, W. G.;
Quintás-Cardama, A.;
Roulston, D.;
Talpaz, M.;
Peterson, L. F.;
Donato, N. J.;
Quintás-Cardama, A

Publication type:

Letter

FES kinases are required for oncogenic FLT3 signaling.

Published in:

Leukemia (08876924), 2010, v. 24, n. 4, p. 721, doi. 10.1038/leu.2009.301

By:

Voisset, E.;
Lopez, S.;
Chaix, A.;
Georges, C.;
Hanssens, K.;
Prébet, T.;
Dubreuil, P.;
De Sepulveda, P.

Publication type:

Article

The degree of myelosuppression during maintenance therapy of adolescents with B-lineage intermediate risk acute lymphoblastic leukemia predicts risk of relapse.

Published in:

Leukemia (08876924), 2010, v. 24, n. 4, p. 715, doi. 10.1038/leu.2009.303

By:

Schmiegelow, K.;
Heyman, M.;
Gustafsson, G.;
Lausen, B.;
Wesenberg, F.;
Kristinsson, J.;
Vettenranta, K.;
Schroeder, H.;
Forestier, E.;
Rosthoej, S.

Publication type:

Article

Lck is a key target of imatinib and dasatinib in T-cell activation.

Published in:

2010

By:

Lee, K. C.;
Ouwehand, I.;
Giannini, A. L.;
Thomas, N. S.;
Dibb, N. J.;
Bijlmakers, M. J.

Publication type:

Letter

Chronic lymphoproliferative disorder of natural killer cells: a distinct entity with subtypes correlating with normal natural killer cell subsets.

Published in:

2010

By:

Morice, W. G.;
Jevremovic, D.;
Olteanu, H.;
Roden, A.;
Nowakowski, G.;
Kroft, S.;
Hanson, C. A.;
Kurtin, P. J.

Publication type:

Letter

Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: identification of 1p31-32 deletion as a prognostic factor in myeloma.

Published in:

2010

By:

Chng, W. J.;
Gertz, M. A.;
Chung, T.-H.;
Van Wier, S.;
Keats, J. J.;
Baker, A.;
Bergsagel, P. L.;
Carpten, J.;
Fonseca, R.

Publication type:

journal article

Role of BCR-ABL-Y177-mediated p27kip1 phosphorylation and cytoplasmic localization in enhanced proliferation of chronic myeloid leukemia progenitors.

Published in:

2010

By:

Chu, S.;
McDonald, T.;
Bhatia, R.

Publication type:

journal article

Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways.

Published in:

Leukemia (08876924), 2010, v. 24, n. 4, p. 843, doi. 10.1038/leu.2010.25

By:

Kobayashi, T.;
Kuroda, J.;
Ashihara, E.;
Oomizu, S.;
Terui, Y.;
Taniyama, A.;
Adachi, S.;
Takagi, T.;
Yamamoto, M.;
Sasaki, N.;
Horiike, S.;
Hatake, K.;
Yamauchi, A.;
Hirashima, M.;
Taniwaki, M.

Publication type:

Article

Targeting PKCδ-mediated topoisomerase IIβ overexpression subverts the differentiation block in a retinoic acid-resistant APL cell line.

Published in:

Leukemia (08876924), 2010, v. 24, n. 4, p. 729, doi. 10.1038/leu.2010.27

By:

McNamara, S.;
Nichol, J. N.;
Wang, H.;
Miller, W. H.

Publication type:

Article

Partial retraction. VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance.

Published in:

2010

By:

Lee, Y K;
Shanafelt, T D;
Bone, N D;
Strege, A K;
Jelinek, D F;
Kay, N E

Publication type:

corrected article

Peptide vaccination elicits leukemia-associated antigen-specific cytotoxic CD8+ T-cell responses in patients with chronic lymphocytic leukemia.

Published in:

2010

By:

Giannopoulos, K.;
Dmoszynska, A.;
Kowal, M.;
Rolinski, J.;
Gostick, E.;
Price, D. A.;
Greiner, J.;
Rojewski, M.;
Stilgenbauer, S.;
Döhner, H.;
Schmitt, M.;
Döhner, H

Publication type:

journal article

NF-kappaB activation mediates resistance to IFN beta in MLL-rearranged acute lymphoblastic leukemia.

Published in:

2010

By:

Tracey, L.;
Streck, C. J.;
Du, Z.;
Williams, R. F.;
Pfeffer, L. M.;
Nathwani, A. C.;
Davidoff, A. M.

Publication type:

journal article

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.

Published in:

Leukemia (08876924), 2010, v. 24, n. 4, p. 756, doi. 10.1038/leu.2010.31

By:

Pellagatti, A.;
Cazzola, M.;
Giagounidis, A.;
Perry, J.;
Malcovati, L.;
Della Porta, M. G.;
Jädersten, M.;
Killick, S.;
Verma, A.;
Norbury, C. J.;
Hellström-Lindberg, E.;
Wainscoat, J. S.;
Boultwood, J.

Publication type:

Article

Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms.

Published in:

Leukemia (08876924), 2010, v. 24, n. 4, p. 687, doi. 10.1038/leu.2010.32

By:

Martelli, A. M.;
Papa, V.;
Tazzari, P. L.;
Ricci, F.;
Evangelisti, C.;
Chiarini, F.;
Grimaldi, C.;
Cappellini, A.;
Martinelli, G.;
Ottaviani, E.;
Pagliaro, P.;
Horn, S.;
Bäsecke, J.;
Lindner, L. H.;
Eibl, H.;
McCubrey, J. A.

Publication type:

Article

Nucleoside analog ARC targets Mcl-1 to induce apoptosis in leukemia cells.

Published in:

2010

By:

Bhat, U. G.;
Gartel, A. L.

Publication type:

Letter

Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation.

Published in:

Leukemia (08876924), 2010, v. 24, n. 4, p. 706, doi. 10.1038/leu.2010.4

By:

Lion, T.;
Kosulin, K.;
Landlinger, C.;
Rauch, M.;
Preuner, S.;
Jugovic, D.;
Pötschger, U.;
Lawitschka, A.;
Peters, C.;
Fritsch, G.;
Matthes-Martin, S.

Publication type:

Article

Leukocytosis is associated with poor survival but not with increased risk of thrombosis in essential thrombocythemia: a population-based study of 311 patients.

Published in:

2010

By:

Girodon, F.;
Dutrillaux, F.;
Broséus, J.;
Mounier, M.;
Goussot, V.;
Bardonnaud, P.;
Chrétien, M. L.;
Maynadié, M.

Publication type:

Letter

gammaH2AX: a sensitive molecular marker of DNA damage and repair.

Published in:

2010

By:

Mah, L.-J.;
El-Osta, A.;
Karagiannis, T. C.

Publication type:

journal article

Nilotinib does not significantly reduce imatinib OCT-1 activity in either cell lines or primary CML cells.

Published in:

2010

By:

Eadie, L.;
Hughes, T. P.;
White, D. L.

Publication type:

research

Specific induction of CD33 expression by E2A–HLF: the first evidence for aberrant myeloid antigen expression in ALL by a fusion transcription factor.

Published in:

2010

By:

Akahane, K.;
Inukai, T.;
Inaba, T.;
Kurosawa, H.;
Look, A. T.;
Kiyokawa, N.;
Fujimoto, J.;
Goto, H.;
Endo, M.;
Zhang, X.;
Hirose, K.;
Kuroda, I.;
Honna, H.;
Kagami, K.;
Goi, K.;
Nakazawa, S.;
Sugita, K.

Publication type:

Letter

SHIP-1 inhibits CD95/APO-1/Fas-induced apoptosis in primary T lymphocytes and T leukemic cells by promoting CD95 glycosylation independently of its phosphatase activity.

Published in:

2010

By:

Charlier, E.;
Condé, C.;
Zhang, J.;
Deneubourg, L.;
Di Valentin, E.;
Rahmouni, S.;
Chariot, A.;
Agostinis, P.;
Pang, P.-C.;
Haslam, S. M.;
Dell, A.;
Penninger, J.;
Erneux, C.;
Piette, J.;
Gloire, G.;
Condé, C

Publication type:

journal article